These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 346132)

  • 21. An inverse correlation between plasma prostacyclin and serum triglycerides.
    Viinikka L; Ylikorkala O
    N Engl J Med; 1980 Jun; 302(25):1424-5. PubMed ID: 6990259
    [No Abstract]   [Full Text] [Related]  

  • 22. Release of prostacyclin into the bloodstream in humans after local blood flow changes.
    Serneri GC; Masotti G; Poggesi L; Galanti G
    Adv Prostaglandin Thromboxane Res; 1980; 7():715-8. PubMed ID: 6989198
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostacyclin in pregnancy.
    Lewis PJ; Boylan P; Friedman LA; Hensby CN; Downing I
    Br Med J; 1980 Jun; 280(6231):1581-2. PubMed ID: 7000245
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostacyclin-stabilising-factor deficiency in thrombotic thrombocytopenic purpura.
    Mikhailidis DP; Dandona P
    Lancet; 1982 Mar; 1(8273):678-9. PubMed ID: 6121983
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of PGI2 by 15-hydroxyprostaglandin-dehydrogenase and delta 13-reductase in different vascular beds of the cat in vivo.
    Förstermann U; Neufang B; Hertting G
    Prostaglandins; 1981 Dec; 22(6):915-32. PubMed ID: 6278537
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet adhesion and aggregation in arteries of rats, rabbits and guinea pigs in vivo and in vitro correlate negatively with their prostacyclin (PG I2) production.
    Tschopp TB; Baumgartner HR
    Agents Actions Suppl; 1979; (4):156-62. PubMed ID: 386741
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostacyclin release in vivo.
    Dandona P; Mikhailidis DP; Jeremy JY
    Lancet; 1983 Apr; 1(8328):823-4. PubMed ID: 6132160
    [No Abstract]   [Full Text] [Related]  

  • 31. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock.
    Fletcher JR; Ramwell PW; Harris RH
    Adv Shock Res; 1981; 5():143-8. PubMed ID: 7030016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 33. PGI2 is not a circulating vasodepressor hormone.
    Pace-Asciak CR; Carrara MC; Levine L
    Prog Lipid Res; 1981; 20():113-6. PubMed ID: 7043476
    [No Abstract]   [Full Text] [Related]  

  • 34. Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
    Dusting GJ; Vane JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I183-7. PubMed ID: 6991150
    [No Abstract]   [Full Text] [Related]  

  • 35. Maternal vascular prostacyclin activity in pre-eclampsia.
    Bussolino F; Benedetto C; Massobrio M; Camussi G
    Lancet; 1980 Sep; 2(8196):702. PubMed ID: 6106815
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostacyclin in haemodialysis and charcoal haemoperfusion.
    Weston MJ
    Contrib Nephrol; 1983; 36():68-72. PubMed ID: 6340952
    [No Abstract]   [Full Text] [Related]  

  • 37. Familial deficiency of a plasma factor stimulating vascular prostacyclin activity.
    Remuzzi G; Marchesi D; Misiani R; Mecca G; de Gaetano G; Donati MB
    Thromb Res; 1979; 16(3-4):517-25. PubMed ID: 390760
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood.
    Jørgensen KA; Pedersen RS
    Thromb Res; 1981 Feb; 21(3):311-5. PubMed ID: 7018005
    [No Abstract]   [Full Text] [Related]  

  • 39. Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis).
    Serneri GG; Masotti G; Poggesi L; Galanti G
    Thromb Res; 1980 Jan 1-15; 17(1-2):197-208. PubMed ID: 6990547
    [No Abstract]   [Full Text] [Related]  

  • 40. Utilization of human serum albumin as drug additives I. Stabilizer of prostacyclin.
    Kurono Y; Ohta N; Ikeda K
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2635-8. PubMed ID: 6754113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.